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Objective: Estimate the frequency and spatial location of rapid femorotibial cartilage thinning or thick-
ening in knees with, or at risk of, osteoarthritis (OA) and examine their association with clinical and
radiographic covariates.
Design: Knee cartilage thickness change over 12 months was measured using magnetic resonance
imaging in the right knee of 757 Osteoarthritis Initiative (OAI) participants that had radiographic ﬁndings
of osteophytes or joint space narrowing (JSN). Thickness changes in individual knees were classiﬁed as
having rapid thinning or thickening or no detectable OA-related change when compared to asymp-
tomatic OAI Control cohort knees.
Results: Cartilage thinning, found in 18.5% of subjects, was more frequent in knees with OAI calculated
KellgreneLawrence grade (cKLG) > 2 (P < 0.001) and with frequent pain (P ¼ 0.047). No link was found
between body mass index, sex, and age and cartilage thinning (P > 0.15). The percent of knees with
thickening was small (4.4%), but greater in knees with frequent pain (P ¼ 0.02). Rapid thinning was most
common in the central (36.4%) and external (32.1%) subregions of the medial weight-bearing femur.
Mean cartilage loss in rapidly thinning subregions ranged from 11.2%/y to 24.6%/y. Knees with cKLG > 2,
but classiﬁed as having no detectable OA-related change had mean cartilage loss rates signiﬁcantly
>0 (0.4%/ye1.3%/y) in 10 subregions.
Conclusion: Most observed subregional changes in OA knees were indistinguishable from changes found
in an asymptomatic cohort, but a fraction of subregions showed rapid progression. The relative frequency
of rapid thinning increases when cKLG > 2, a classiﬁcation closely associated with JSN and/or frequent
knee pain are present.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Fast progression in osteoarthritic (OA) knees is a fairly prevalent
concept and inclusion of such knees in clinical trials is desirable, as
improvement from therapeutic intervention could be shown over
shorter time intervals1e8. The concept of “fast” structural progres-
sion is not well deﬁned, however, limiting its usefulness. This study
explores the distribution of change in cartilage thickness in OA and
at risk knees, as measured with magnetic resonance imaging (MRI).to: R.J. Buck, StatAnswers
MN 55401, USA.
).
s Research Society International. PIf cartilage thickness change is a characteristic of knee OA, the
distribution of cartilage thickness change for an OA cohort should
differ from the distribution for asymptomatic knees9. This can occur
because: (1) the population’s mean changes, (2) the standard
deviation (SD) changes, or (3) the shape of the distribution changes.
Generally the focus of previous studies has been about changes in
the population mean1e8. Besides a difference in mean change,
however, cohorts of symptomatic knees have larger variances with
the distribution having heavier tails skewed toward larger cartilage
losses than asymptomatic knees4,5.
What is the best way to characterize these skewed distribu-
tions? The best approach may be to separate knees into three
classes: those with rates of change indistinguishable from non OA-
related change and two classes for those that are distinguishableublished by Elsevier Ltd. All rights reserved.
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OA-related thinning or thickening. Note that if an individual was
classiﬁed as having no detectable OA-related change this does not
imply no OA-related change occurred, just that change was indis-
tinguishable from the reference cohort.
A recently proposed method classiﬁed individual knee
progression over 2 years4. The method compared individual
changes to an asymptomatic reference sample and statistically
identiﬁed whether an individual knee’s observed change came
from this reference distribution. Change in most OA knees was
negligible and not distinguishable from change observed in
asymptomatic subjects, while a small percentage of knees had
large localized changes in cartilage thickness4. The earlier study
only examined knees of women with medial femorotibial disease,
frequent knee pain, and KellgreneLawrence grades (KLGs) of
2 or 3.
The current study applies the proposed method to change over
1 year to a larger sample of men and women from the Osteoar-
thritis Initiative (OAI) study5,6. Besides including men, the current
study expands the range of radiographic disease stage beyond
KLG2 and KLG3, does not restrict disease to the medial femo-
rotibial compartment, and includes knees without frequent
pain5,6.
This study explores the following questions.
1 What is the relative frequency of rapid cartilage progression
(thinning or thickening) in knees from the OAI with radio-
graphic or symptomatic OA?
2 What spatial subregions most frequently show rapid
progression?
3 Is there an association between rapid progression and age,
body mass index (BMI) and sex?
4 Is there an association between rapid progression and frequent
knee pain, joint space narrowing (JSN), and osteophyte (OP)
status?
5 While knees may not individually be separable from the
variation observed in an asymptomatic reference distribu-
tion, is the mean change of this group signiﬁcantly different
from zero and are these changes associated with demo-
graphic or OA characteristics examined for rapid
progression?Table I
Cohort demographics: summary of age, BMI, (mean and SD), and frequency of men, OPs, k
full cohort and observed sample
Sample size Progression cohort Incidence coh
Full cohort Study sample Full cohort
1352 416 2521
Mean SD Mean SD Mean
Age 61.4 9.1 61.4 9.4 62.0
BMI 30.2 4.9 30.4 4.7 28.4
N (%) N (%) N
Number men 575 42.5 180 43.3 1030
OP 1173 86.8 393 94.5 1029
Frequent pain 1053 77.9 328 78.8 474
Normal 0 0.0 0 0.0 0
Doubtful 178 13.2 22 5.3 1481
Minimal 430 31.8 158 38.0 502
Moderate 540 39.9 163 39.2 457
Severe 204 15.1 73 17.5 81
For the Progression cohort, the knee qualiﬁes if it has OP and frequent knee pain, while fo
Inclusion in the Incidence cohort relies on age and sex speciﬁc qualiﬁcations that generally
along with non-knee speciﬁc qualiﬁcations they qualiﬁed as an Incidence cohort knee. No
data version 0.2.2.Methods
Study population
The OAI is an ongoing study with three cohorts, Progression
(n ¼ 1,352), Incidence (n ¼ 2,521), and Control (n ¼ 122), to
investigate risk factors associated with progression of symptom-
atic knee OA and identify biomarkers of the disease8,10. Men and
women, ethnically diverse and 45e79 years old, were recruited
from four clinical sites. Exclusion criteria were rheumatoid or
inﬂammatory arthritis, bilateral end stage knee OA, inability to
walk without aids, and MRI contraindications8. This study includes
the right knee of 757 participants selected from the ﬁrst half of the
OAI Progression and Incidence subcohorts (public-use data sets,
0.2.2, 0.C.1 and 1.C.1) and included all available cases with an OAI
calculated Kellgrene-Lawrence grade (cKLG) of four at baseline
and a convenience sample of knees with cKLG2 or cKLG3 at
baseline (either selected by ascending OAI identiﬁers or from an
age- and sex-stratiﬁed subject subsample created for a separate
study). Details of sample selection have been described
previously5,6.
Progression cohort subjects had at least one knee with femo-
rotibial knee OA at baseline deﬁned as having both frequent knee
pain8, i.e., pain, aching or stiffness around the knee on most days
within a month sometime in previous 12 months, and radiographic
evidence of deﬁnite OPs on ﬁxed ﬂexion radiographs8,11. Charac-
teristics of the subsample (N ¼ 416, 180 men, 236 women) from the
Progression cohort included here matched the full Progression
cohort for age, BMI, sex distribution, presence of OPs and pain, and
cKLG in right knee fairly well (Table I).
Incidence cohort subjects did not have knee OA at baseline, but
had characteristics that place them at increased risk for developing
knee OA during the study8,10. Knees could have deﬁnite OPs or
frequent knee pain, but not both. Characteristics of this subsample
(N ¼ 341, 123 men, 228 women) of the Incidence cohort matched
the full Incidence cohort for age, BMI, and sex distribution, but the
knees had higher frequency of OPs and lower rates of pain (Table I).
The subjects selected from the Incidence cohort closely matched
the Progression cohort except for the prevalence in knee pain,
which was rare in the Incidence cohort and present in the
Progression cohort.nee pain, and different OA grades (cKLG) of subject right knee for each OAI cohort for
ort Control cohort
Study sample Full cohort Study sample
341 122 112
SD Mean SD Mean SD Mean SD
9.2 64.0 9.1 55.0 7.7 55.0 7.7
4.7 28.7 4.5 24.3 3.1 24.3 3.0
(%) N (%) N (%) N (%)
40.9 123 36.1 47 38.5 43 38.4
40.8 323 94.7 0 0.0 0 0.0
18.8 14 4.1 0 0.0 0 0.0
0.0 0 0.0 122 100.0 112 100.0
58.7 13 3.8 0 0.0 0 0.0
19.9 156 45.7 0 0.0 0 0.0
18.1 136 39.9 0 0.0 0 0.0
3.2 36 10.6 0 0.0 0 0.0
r the Incidence cohort, the knee likely qualiﬁes except knees with no OP and no pain.
are not knee speciﬁc. The presumption is that if a knee had pain or OP, but not both,
pain criteria is from P01*KSX¼ 2 and P01*XRKOA¼ 1 from OAI baseline biomarkers
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Fig. 1. Rate of cartilage thickness change (mm/y) in ecMF subregion vs ecMF cartilage
thickness (mm) at baseline. Squares represent ecMF change of women, triangles men.
Filled symbols are ecMF designated rapid progressors, unﬁlled symbols are ecMF
designated as having no detectable OA-related change. Horizontal lines represent 2.5%
and 95.5% percentiles of reference distribution (OAI Control cohort) for ecMF; solid line
is for men, dashed line is for women.
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the Control cohort (public-use data sets 0.2.2, 0.F.1 and 1.F.1)5,12
were used as a reference sample to deﬁne cartilage thinning and
thickening as described previously4. Control cohort subjects had no
pain or radiographic (ﬁxed ﬂexion) ﬁndings of femorotibial OA
[Osteoarthritis Research Society International (OARSI) OP grade
0 and JSN grade 0] in either knee, and no risk factors for the onset of
knee OA, including obesity, history of knee injury, knee surgery,
family history of knee replacements, or Heberden’s nodes5,12.
MRI acquisition and image analysis
Cartilage thickness was measured from double oblique, coronal
fast low angle shot MR images with water excitation (slice thick-
ness 1.5 mm, in-plane resolution 0.31 mm  0.31 mm) as described
in the OAI MRI acquisition protocol8,13. The images (baseline and
follow-up) were read in pairs with readers blinded to visit5,6,14.
Quality control readings of all segmentations were performed by
one of two expert readers (SM or FE)5,6,14. Cartilage thickness was
measured over the total subchondral bone area (ThCtAB), as
deﬁned previously5,14e16. Change in ThCtAB (DThCtAB) was
measured in 16 subregion, three subregions (central, external,
internal) in both the weight-bearing medial (cMF) and lateral
femur (cLF), i.e., ccMF/LF, ecMF/LF, and icMF/LF, and ﬁve subregions
(central, external, internal, anterior, posterior) in both the medial
(MT) and lateral tibia (LT), i.e., cMT/LT, eMT/LT, iMT/LT, aMT/LT,
pMT/LT5,14,16. Scan/rescan reproducibility for subregion cartilage
thickness has been reported as between 1.4% and 4.7%16.
Deﬁning rapid progression
The method to determine whether individual knees had rapid
thickening or thinning over time compared to a reference cohort
has been reported previously; 4 in the current study the OAI Control
cohort9 was used as the reference cohort. Brieﬂy, to assess whether
knees had undergone rapid change in cartilage thickness in
a particular subregion, values were ﬁrst normalized by dividing by
the Control cohort SD of change for the relevant subregion and sex9.
Mean change in the reference cohort was assumed to be zero9.
Normalized values were assumed to be from a standard normal
distribution and were translated into P-values4. Subregion and
individual knee changes were classiﬁed as No detectable OA-
related Change, detectable or rapid thinning or thickening by
examining the P-values as separate tests and using false discovery
rates (FDR), a ¼ 0.1, to adjust for multiple comparisons. For brevity,
the classeswill be called no change, thinning and thickening. Testing
was done for thinning and thickening classiﬁcation separately4.
Classiﬁcation was carried out on the Control cohort separately from
the combined Incidence and Progression cohorts. If neither thin-
ning nor thickening were determined to have occurred, a knee’s
subregion was classiﬁed as having No detectable OA-related
Change or simply no change4. The above algorithm describes
classiﬁcation for individual subregions. A knee was deﬁned as
having thinning (thickening) if any subregion was classiﬁed as
having thinning (thickening)4. A knee was deﬁned as having
progression if either thinning or thickening took place. Change and
classiﬁcations for ecMF are presented as an example (Fig. 1). Note
the term progression has taken on two uses: describing change and
describing one of the cohorts of the study; its use with cohort will
be capitalized, i.e., Progression cohort.
Statistical analysis
Knee level summaries for frequency of thinning and thickening
were broken down by presence/absence of OPs, OAI cKLG5, andpresence/absence of frequent pain at baseline6. The cKLGs were
created from individual radiographic feature (IRF) OP and JSN
scores with cKLG0 (normal): OP and JSN scores ¼ 0; cKLG1
(doubtful): OP and JSN scores ¼ 1, but scoress 1 for both; cKLG2
(minimal): OP score ¼ 2 (deﬁnite) and JSN score ¼ 0 (or no deﬁnite
OP and JSN score ¼ 2); cKLG3 (moderate): deﬁnite OP and JSN
score ¼ 1; cKLG4 (severe): deﬁnite OP and JSN score ¼ 25. While
knees with JSN > 0 are possible in cKLG1/2, this was rare with
JSN > 0 in 6.9% of cKLG1/2 knees. Note that JSN scores mentioned
here are the OAI JSN IRF scores, which have equivalent deﬁnitions
to the OARSI JSN grade5 except that OAI score 1 combines OARSI
grades 1 and 2 and that OAI score 2 corresponds to OARSI grade 3.
Logistic regression was used to assess whether age, BMI, sex,
presence/absence of frequent knee pain in last 12 months, OPs or
cKLG at baseline were associated with presence of thinning
(thickening). Hypotheses tested for the multi-level factor cKLG
included doubtful vs minimal, moderate vs severe, and doubtful
and minimal vs moderate and severe radiographic knee OA. Note
that the latter test is nearly equivalent to a test for effect of JSN,
since few cKLG1/2 knees had JSN > 0 and all cKLG3/4 knees had
JSN > 0. Cohort was included as a factor to examine whether
untested characteristics of the different cohorts were creating
different prevalence rates. Regression models were constructed to
test whether DThCtAB in the knees not classiﬁed as progressing
were associated with age, BMI, sex, pain, or cKLG. Due to (expected)
lack of progression, Control cohort knees were not included in the
analysis.
Summary statistics were computed for DThCtAB in knees that
did not progress and Shapiro test was used to assess whether these
knees were normally distributed. The Bonferroni method for
multiple comparison (a ¼ 0.05) was used as a simple guide to
interpreting the signiﬁcance of multiple tests. Analyses were per-
formed using Splus v6.2 (TIBCO Software Inc.).Results
A total of 167 (22.1%) of all 757 Progression and Incidence cohort
knees were classiﬁed as having rapid progression. Most knees with
progression had only thinning, N ¼ 134 (17.7%), while 27 (3.6%)
knees had only thickening and six (0.8%) had both thinning and
Table III
Estimates of OR, with 95% CI lower (LB) and upper bounds (UB), for thinning vs no
thinning in logistic regression model with sex, age, BMI, and OA grade (cKLG) as
factors
Factor OR 95%
LB
OR OR 95%
UB
P-value
(H0: OR ¼ 1)
Sex: male/female 0.69 1.01 1.49 0.9540
Age 0.96 0.98 1.01 0.1518
BMI 0.97 1.01 1.06 0.4779
cKLG: minimal/doubtful 0.23 0.60 1.58 0.3004
cKLG: severe/moderate 0.89 1.46 2.40 0.1326
cKLG: (mod þ sev)/(min þ doub) 1.46 2.49 4.26 0.0008
Pain/no pain 1.01 1.48 2.18 0.0468
Comparisons for multi-level cKLG were for minimal vs possible OA, severe vs
moderate, and moderate or greater vs minimal or less. Factor description identiﬁes
the numerator and denominator of the OR, e.g., minimal/doubtful. P-value is for test
whether OR ¼ 1 for given factor. cKLG and pain OR are with sex, age, and BMI not
included in the model.
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progression was not evenly distributed between the cohorts
(P¼ 0.001), with 56 (16.4%) Incidence cohort knees, and 111 (26.7%)
Progression cohort knees identiﬁed as having progression in at
least one subregion. To assess the methodology progression, clas-
siﬁcation was carried out on the Control cohort and only two (1.8%)
knees were found to have progression.
Progression rates were similar in men (N ¼ 67, 19.4%) and
women (N¼ 102,19.5%). Rates for thinning,17.1% for men and 15.7%
for women, and thickening, 3.2% for men and 4.6% for women, were
also similar. Tests for the demographic covariates (age, BMI, and
sex) to predict thinning were not signiﬁcant when included in
a model on their own (P ¼ 0.5) or after adjusting for presence of
frequent pain or OPs (P > 0.35).
Rate of thinning in knees with frequent pain was 22.8%
compared to 14.9% in knees without frequent pain (Table II). Rate of
thinning was 18.6% in knees with and 17.1% without OPs (Table II).
The presence of pain was a signiﬁcant predictor of thinning
(P ¼ 0.005), but not the presence of OPs (P ¼ 0.63). The odds ratio
(OR) for rapid thinning when comparing presence/absence of
frequent painwas 1.7 [95% conﬁdence interval (CI)¼ 1.17, 2.46] and
for OPs was 1.23 (0.53, 2.84). It should be noted that when the OR
deviates from one and the relative frequency of the outcome is
large (>10%) as it is here for rapid thinning the OR does not esti-
mate relative risk well.
Knees with cKLG1 (17.1%) had higher frequency of thinning than
knees with cKLG2 (9.9%), but the difference was not statistically
signiﬁcant (P¼ 0.3). Frequency of thinning was signiﬁcantly greater
in knees with cKLG3 (22.7%) and cKLG4 (32.1%) than in cKLG1 and
cKLG2 knees (P < 0.001, Tables II, III), but there was no signiﬁcant
difference in frequency between cKLG3 and cKLG4 (P ¼ 0.13,
Table III). Frequent painwas still a signiﬁcant predictor of increased
frequency of thinning when cKLG was included in the model
(P ¼ 0.047, Table III). Adjusting for cKLG rather than presence/
absence of OPs did not lead to demographic covariates being
signiﬁcant predictors of thinning (P > 0.15, Table III).
The percent of knees with thickening was small (Table II). Knees
with frequent pain had a signiﬁcantly higher frequency of thick-
ening than knees without frequent pain (P ¼ 0.02). Although there
was a general increase in frequency of thickening with increasing
cKLG (Table II), differences between cKLG groups were not signiﬁ-
cant (P ¼ 0.51).
The ccMF, ecMF, and eMT were the most common subregions
with thinning (36.4%, 32.1%, and 24.3% of knees, respectively)
(Table IV). While the number of knees with thickening was small,
almost half (45.5%) the knees with thickening had thickening in the
ecMF (Table IV). Thinning and thickening both seemed to be moreTable II
Percent of subjects with progression (thinning or thickening) in subjects with or
without frequent pain and OPs or with different grades of radiographic OA
No frequent pain Frequent pain All
N %Thin %Thick N %Thin %Thick N %Thin %Thick
OP in
No OP 15 13.3 6.7 26 19.2 0.0 41 17.1 2.4
OP 400 15.0 2.5 316 23.1 7.0 716 18.6 4.5
cKLG
Doubtful 10 20.0 10.0 25 16.0 0.0 35 17.1 2.9
Minimal 195 9.7 2.1 119 10.1 5.0 314 9.9 3.2
Moderate 174 19.5 2.9 125 27.2 7.2 299 22.7 4.7
Severe 36 19.4 2.8 73 38.4 9.6 109 32.1 7.3
Total 415 14.9 2.7 342 22.8 6.4 757 18.5 4.4
Frequent knee pain was a signiﬁcant predictor of thinning (P ¼ 0.005) and thick-
ening (P¼ 0.02). Frequency of thinning was signiﬁcantly greater in knees with cKLG
3 than in knees with cKLG 2 knees (P < 0.001).uniformly distributed across subregions in the lateral compartment
than in the medial compartment.
Mean DThCtAB in subregions with thinning ranged
between 0.21 mm/y (pMT from one knee) and 0.47 mm/y (cLT
from 18 knees) and was comparable to a percent cartilage loss of
11.2e24.6% (Table V). The ecMF, where thickening was observed
most frequently (15 knees), had an average increase of 0.21 mm/y
(Table V).
Mean DThCtAB was examined in knees classiﬁed as having no
detectable OA-related change. Cartilage loss in cKLG4 knees was
greater than in cKLG3 knees in 15 of 16 subregions,which in turn had
more cartilage loss than cKLG2 knees in 14 of 16 subregions
(Table VI). Mean percent change in cartilage thickness averaged over
all subregions was 0.34%/y, 0.12%/y, 0.41%/y, and 0.84%/y in
cKLG1e4 knees, respectively. The number of subregions with
a statistically signiﬁcant mean DThCtAB from zero increased with
cKLG (zero in cKLG1, two in cKLG2, ﬁve in cKLG3, 10 in cKLG4 after
adjusting for multiple comparisons using FDR) even though the
number of knees in cKLG4 subcohort was only a third of those in
cKLG2 and cKLG3 subcohorts. The cLT and iLT regions had signiﬁcant
mean DThCtAB in cKLG2-4 subcohorts, while cMT, pMT, icMF were
signiﬁcant in cKLG3/4 subcohorts, with eMT, iMT, pMT, ccMF, and eLT
signiﬁcant only in cKLG4 (Table VI). Subregions with signiﬁcant
DThCtAB had percent thickness changes between 1.3%/y
and 0.9%/y in cKLG4 subcohort, 1.0%/y to 0.6%/y in cKLG3 sub-
cohort, and 0.7%/y to 0.5%/y in cKLG2 subcohort.
When testing for differences between sexes in mean DThCtAB in
knees classiﬁed as having No Change only ecMF had P-values< 0.05
(P-value ¼ 0.0038), but this was not signiﬁcant after adjusting for
multiple comparisons (Bonferroni, a ¼ 0.05). No subregions had
P-values < 0.05 when testing for differences between No ChangeTable IV
Percent of speciﬁed subregion with thinning (or thickening) in subjects with thin-
ning (or thickening)
Region Thinning (N ¼ 140) Thickening (N ¼ 33)
Medial Lateral Medial Lateral
c*T 15.0 12.9 3.0 0.0
e*T 24.3 13.6 3.0 6.1
i*T 6.4 4.3 0.0 3.0
a*T 2.1 1.4 0.0 0.0
p*T 0.7 2.9 3.0 0.0
cc*F 36.4 12.9 12.1 6.1
ec*F 32.1 17.1 45.5 21.2
ic*F 10.7 10.7 6.1 21.2
Note percentages do not sum to 100% as some subjects had progression in multiple
subregions.
Table V
Mean and SD of subjects with thinning or thickening in speciﬁed subregion
Region Thinning Thickening
N Mean %Mean SD %SD N Mean %Mean SD %SD
cMT 21 0.36 16.1 0.120 5.3 1 0.299 16.6
eMT 34 0.28 24.2 0.212 18.3 1 0.184 16.5
iMT 9 0.23 11.2 0.046 2.3 0
aMT 3 0.35 23.6 0.203 13.8 0
pMT 1 0.21 15.6 1 0.275 17.5
ccMF 51 0.37 19.2 0.223 11.8 4 0.376 25.4 0.168 11.3
ecMF 45 0.24 17.8 0.146 10.9 15 0.211 16.7 0.067 5.3
icMF 15 0.32 18.3 0.144 8.3 2 0.328 17.0 0.073 3.8
cLT 18 0.47 17.3 0.178 6.5 0
eLT 19 0.25 18.6 0.099 7.2 2 0.363 20.3 0.154 8.6
iLT 6 0.39 24.6 0.208 13.2 1 0.351 21.6
aLT 2 0.31 20.0 0.072 4.6 0
pLT 4 0.35 18.3 0.024 1.3 0
ccLF 18 0.38 17.1 0.131 5.9 2 0.328 13.6 0.002 0.1
ecLF 24 0.26 18.7 0.079 5.8 7 0.205 11.9 0.034 2.0
icLF 15 0.25 13.3 0.052 2.8 7 0.227 12.8 0.053 3.0
N is number of subjects with relevant progression for that subregion. Percent is
percent change from baseline.
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between No Change knees with different cKLGs found
P-values< 0.05 for DThCtAB in cMT (P¼ 0.014), eLT (P¼ 0.015), and
aLT (P ¼ 0.021), but none were signiﬁcant after adjusting for
multiple comparisons. Tests to assess normality for distributions of
knees with no detectable change found P-values < 0.05 for eMT
(P ¼ 0.0007), iMT (P ¼ 0.03), ccMF (P ¼ 0.033), cLT (P ¼ 0.036), and
eLT (P ¼ 0.007), but only the test on the distribution for eMT was
signiﬁcant after adjusting for multiple comparisons.Discussion
The method used to classify knee progression was introduced
previously4, but only examined knees of women with pain with
KLGs of 2 or 3. The current study included men and women, knees
with and without frequent pain, and expanded the range (cKLG1e
cKLG4) and locations (medial and lateral) of disease stage
considered5,6.
Most knees classiﬁed as having rapid progression showed rapid
cartilage loss. Earlier work indicated cartilage thinning was asso-
ciated with varus malalignment in the same regions found to haveTable VI
Percent rate of change and standard error in subregional ThCtAB (mm/y) for subjects cla
Region Doubtful Minimal
Mean (SE) P-value Mean (SE) P-value
cMT 0.1 (0.7) 0.8346 0.1 (0.2) 0.6550
eMT 0.7 (0.5) 0.1745 0.0 (0.2) 0.9610
iMT 0.3 (0.5) 0.5642 0.1 (0.2) 0.5511
aMT 0.8 (0.8) 0.3237 0.2 (0.2) 0.3286
pMT 0.3 (0.6) 0.6516 0.0 (0.2) 0.8482
ccMF 1.0 (0.6) 0.1362 0.4 (0.2) 0.0296
ecMF 0.5 (0.7) 0.4998 0.2 (0.2) 0.4468
icMF 0.4 (0.6) 0.4967 0.3 (0.2) 0.0935
cLT 0.7 (0.5) 0.1574 0.5 (0.1) 0.0011
eLT 0.1 (0.5) 0.9153 0.2 (0.2) 0.2847
iLT 1.9 (0.6) 0.0039 0.7 (0.2) 0.0002
aLT 0.8 (0.7) 0.2735 0.0 (0.2) 0.8806
pLT 1.0 (0.7) 0.1551 0.5 (0.2) 0.0638
ccLF 0.2 (0.6) 0.7091 0.1 (0.2) 0.7635
ecLF 0.9 (0.7) 0.2078 0.2 (0.2) 0.4121
icLF 0.3 (0.6) 0.6895 0.1 (0.2) 0.6307
P-values for the hypothesis mean rate of change is signiﬁcantly different from zero. P-val
comparisons (FDR, a ¼ 0.05).rapid thinning (ecMF, ccMF, and eMT)17. The average loss rates, 11e
25%/y, for subregions classiﬁed as having rapid thinning are clearly
unsustainable over the long-term. The majority of subregions were
shown to have minimal changes, indicating these rapid losses may
be countered by periods of stasis, where little or no change occurs.
While thinning is the predominant change observed, some
knees undergo cartilage thickening as part of disease progression.
Past work has also shown cartilage thickening in early stages of
knee OA. Cartilage was thicker in a KLG2, but not KLG3, cohort
when compared to a KLG0 cohort in a cross-sectional study18 and
also in a paired knee comparison when OPs were present locally19.
Longitudinal cartilage thickening has been reported in the cMF of
subjects with recent anterior cruciate ligament injuries20,21. In early
knee OA animal models, thickening has been interpreted by some
as sign of cartilage hypertrophy22,23 and by others as sign of cartilage
swelling24e26 with an increase in water content due to rupture of
the collagen matrix. Further work is needed to determine whether
thickening in these situations is due to general thickening across all
subjects or due to a proportion of subjects showing rapid thickening.
The risk factors sex, age, and BMI were not signiﬁcant predictors
of either thinning or thickening. Other studies have also shown
little relationship between these factors and short-term changes in
cartilage thickness27e29. Subjects were at many different disease
states at baseline and risk associatedwith these disease factors may
vary with disease state; hence possibly leading to a reduced risk of
cartilage loss30.
Rapid progression was not signiﬁcantly related to the presence
of OPs, but the numbers of subjects with and without OPs were
highly imbalanced (19e1), limiting the power of this comparison.
The frequency of thinning was signiﬁcantly greater in knees with
frequent pain6 and in those with cKLG3/45,31, where JSN is present.
Examination of the knees classiﬁed as having no detectable OA-
related change indicated that while OA-related change was not
detectable, OA-related change was likely present, at least in knees
with higher cKLG. Mean DThCtAB appeared to increase with cKLG5
with mean percent loss of about 0.9e1.35% in 10 subregions from
cKLG4 knees, 0.4% and 1.0% in nine subregions of the cKLG3
knees, and negligible changes (0.25e0.25%) in 13 of 16
subregions of cKLG2 knees. Sample sizes for cKLG1 knees were
too small to draw ﬁrm conclusions. This study was not designed
to address this question, but it appears that slow progression may
be conﬁned to single locations in cKLG2 knees, while cKLG4
knees appear to have a more global change.ssiﬁed as having no change from subcohorts of calculated cKLGs 1e4
Moderate Severe
Mean (SE) P-value Mean (SE) P-value
0.6 (0.2) 0.0023 1.3 (0.4) 0.0021
0.4 (0.2) 0.0394 0.9 (0.4) 0.0192
0.3 (0.2) 0.1384 0.9 (0.4) 0.0197
0.2 (0.2) 0.3351 0.7 (0.6) 0.1933
0.4 (0.2) 0.0573 1.0 (0.4) 0.0173
0.6 (0.2) 0.0047 0.9 (0.4) 0.0237
0.6 (0.3) 0.0279 0.0 (0.4) 0.9819
0.8 (0.2) 0.0003 1.3 (0.4) 0.0056
0.9 (0.2) <0.0001 1.1 (0.3) 0.0001
0.4 (0.2) 0.0458 1.3 (0.3) 0.0001
1.0 (0.2) <0.0001 1.0 (0.4) 0.0051
0.3 (0.2) 0.2646 1.2 (0.5) 0.0116
0.3 (0.3) 0.2361 0.7 (0.4) 0.0600
0.1 (0.3) 0.5936 0.4 (0.5) 0.3602
0.2 (0.3) 0.4504 0.3 (0.4) 0.4948
0.1 (0.2) 0.6267 0.5 (0.4) 0.2730
ues in bold font indicate signiﬁcant difference from zero after adjusting for multiple
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zero, previous work indicates that loss rates of up to 0.5%/y in
asymptomatic knees cannot be excluded as a possibility5,9. Even
under this aggressive estimate of loss for asymptomatic knees, it
appears that knees with JSN (cKLG3/4) show slow progression over
large areas of the cartilage. Hence it appears that in knees with JSN
(cKLG3/4) and initially characterized as having no detectable OA-
related change a slow rate of cartilage loss exists on average,
while the label No Change appears appropriate for cKLG1/2 knees,
which predominantly had no JSN. This may indicate early sites of
cartilage loss and agrees with ﬁndings from a cross-sectional,
population based study that knees with OPs but without JSN
(KLG2) had no detectable general cartilage loss, but focal lesions in
MRI32.
A typical summary for this study would note the mean and SD
of the sample. This tends to emphasize the behavior of the
majority of knees. Considering the sample as a mixture of rapid
progressors and slow/no progressors highlights important char-
acteristics of the empirical distribution, e.g., frequency of rapid
progressors and underlying means and SDs of each progression
class. Characterizing individual behavior has multiple beneﬁts.
This information not only increases understanding of the disease,
but also can be used to improve the sensitivity of change, e.g., by
recognizing that simple averages are affected by lumping subjects
with thinning and thickening into one summary. The use of
ordered values helps resolve this problem by sorting thinning
subregions from thickening subregions during comparison
between groups29,33,34.
The percent and mean change of knees with rapid progression
are biased estimates for all knees with OA-related progression.
Subjects with smaller, but real OA-related progression are not
separable from observed natural variability. Evidence indicates
that, in general, the knees classiﬁed as rapid progressors are not
just being selected from the tail of a slow progression subcohort, as
most knees identiﬁed as having thinning remained classiﬁed as
such after adjusting the reference cohort to reﬂect the rates
observed in the No Change group. Subregion cartilage changes in
the No Change class were approximately normally distributed,
indicating indirectly that the No Change class distribution is not
being truncated by falsely classifying large numbers of knees as
rapid progressors. These results indicate that this ﬁrst approxima-
tion for delineating knees into different progression groups may be
reasonable.
It is unclear whether covariates such as age and BMI effect
cartilage thickness change in asymptomatic subjects, but indica-
tions are that effects are likely to be small9. If these covariates affect
DThCtAB in the reference cohort, this could lead to biases in clas-
siﬁcation as the reference cohort was younger and had lower BMI
than the OA and at risk subjects. Sensitivity analyses examining the
effect of errors in parameterization of the reference cohort indicate
that the relative bias is likely <10%9.
Three general approaches for examining DThCtAB have been
discussed in the literature: DThCtAB in plates or compartments,
in subregions3,14,17,35, or ordered values of subregion
DThCtAB5,6,29,33,34. The sensitivity of all these cartilage thickness
metrics for disease progression could be improved by better
understanding which subregions are most likely to undergo rapid
progression. Results indicate that few individuals undergo rapid
thinning in the aMT, aLT, pMT, or pLT, with the possibility that iMT
and iLT belong in this group as well. By removing these subregions
from consideration (1) plate or compartment averages are likely to
have increased sensitivity due to increased signal to noise, (2)
subregions will have increased sensitivity due to reduced number
of comparisons that need to be made (think Bonferroni multiple
comparison being reduced from 0.05/16 to 0.05/10, that is nearlya 40% improvement), and (3) the reduced number of subregions
included in the ordered values would likely lead to reduced vari-
ability in the extreme ordered values (fewer subregions to produce
extreme values from null distribution).
This study examined the relative frequency of rapid progression
in knees from the OAI with a wide range of OA-related character-
istics. Results highlight the discrepancy in location and magnitude
of thickness change between subjects. The relative frequency of
rapid thinning increased with cKLG (particularly when JSN was
present), and presence of knee pain, but was independent of sex.
Slow OA-related cartilage loss appears to exist in cKLG3/4 knees
that showed no detectable OA-related change.
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